november AG
Changes in Supervisory Board of november AG
Ad-hoc-announcement transmitted by DGAP.
The issuer is solely responsible for the content of this announcement.
——————————————————————————–
Changes in Supervisory Board of november AG
Erlangen (Germany), 20 July 2004. Prof. Dr. Dr. h.c. Karl Wilhelm Pohl
(Cologne/Germany) has for personal reasons asked to be immediately released of
his duties as Chairman of the Supervisory Board of the biotech company november
AG (ISIN DE0006762909) and will leave the Supervisory board on his own request.
Prof. Pohl had been member of the Supervisory Board of november AG since
December 2002.
Dr. Agniezka Jankowska (Rheinfeld/Switzerland) is now joining november AG’s
Supervisory Board. She is a business consultant and holds academic degrees in
political sciences and economics. During her career within the multinational
chemical, pharmaceutical and diagnostics industry, she has specialized on
technology transfer and industrial alliances. On her last position between 1992
and 1998 with F. Hofmann-La Roche (Switzerland), she was in charge of licensing
agreements regarding PCR, a key technology for molecular biology. Since 1999 she
is managing partner of the consulting firm AKonsult where she successfully
supported november AG’s subsidiary PEQLAB Biotechnologie GmbH in the field of
strategic business development.
A new Chairman of the Supervisory Board will be elected at the next ordinary
board meeting in September. Until then, the board will be headed by the current
Deputy Chairman Dr. Leo Steib (Feucht/Germany).
The members of the Supervisory Board, the Board of Directors and the Management
of november AG regret Prof. Pohl’s decision. “Prof. Pohl was always very
committed to support november AG”, stated Dr. Wolf M. Bertling, CEO of november
AG. “This holds especially true for the restructuring phase that we have just
successfully completed. He was also very active in planning and shaping our
commercial success and was successfully supporting our current negotiations with
strategic partners. Considering these achievements we thank him for his always
excellent collaboration.”
For additional information please contact:
Dr. Peer Nils Schröder
november AG – Investor Relations
Ulrich-Schalk-Str. 3, D-91056 Erlangen
Tel.: +49 (0)9131 750 88 868
e-mail: schroeder@november.de
http://www.november.de
end of ad-hoc-announcement (c)DGAP 20.07.2004
——————————————————————————–
WKN: 676290; ISIN: DE0006762909; Index:
Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin-
Bremen, Düsseldorf, Hannover, München und Stuttgart
201742 Jul 04
Latest News
Latest Reports
Upcoming Events
No Events found
Webcasts
No Webcasts found